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Available online 09 November 2016Background:Modern imaging technology has improved detection of left ventricular non-compaction cardiomy-
opathy (LVNC). Hypertrophic cardiomyopathy (HCM) shares morphological features with LVNC, but prognosis
and treatment strategies differ between LVNC and HCM.
Methods and results:Weaimed to compare global and regional LVmyocardial function in LVNC andHCM.We hy-
pothesized that apical function is reduced in LVNC due to the embryonic reduced compaction of the apex. We
studied 25 patients with LVNC (47 ± 14 years) according to current criteria, 50 with HCM (47 ± 14 years)
and 50 healthy individuals (49 ± 19 years). By echocardiography, we assessed maximal wall thickness (MWT)
and LV ejection fraction (EF). Numbers of trabeculations were counted from 3 apical views. Global longitudinal
strain by speckle tracking echocardiographywas calculated from a 16 LV segmentsmodel. LV basal (6 segments)
and apical (4 segments) longitudinal strainswere averaged. MWTwas thinner, EF lower and trabeculationswere
more pronounced in LVNC compared toHCM (all p b 0.001) butwith no signiﬁcantly differences in LV global lon-
gitudinal strain (−15.1± 6.1 vs.−16.8 ± 3.7, p = 0.14). Function by longitudinal strain increased signiﬁcantly
from base to apex in HCM (−14.9± 4.3% vs.−19.5± 4.7%, p b 0.001) and in healthy controls (−20.0± 1.9% vs.
−21.8 ± 2.9%, p b 0.001), but not in LVNC (−14.7 ± 6.4% vs.−15.7 ± 7.2%, p = 0.35).
Conclusions: Increased number of trabeculations, thinner MWT and lower EF were characteristics of LVNC. Myo-
cardial functionwas homogeneously reduced in LVNC, while an apical to basal gradientwith relatively preserved
apical function was present in HCM. These characteristics may help to discriminate between LVNC and HCM.
© 2016 The Author(s). Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Left ventricular non-compaction cardiomyopathy (LVNC) is a rare
condition with high morbidity and mortality due to malignant arrhyth-
mias, systemic thrombotic embolism and heart failure [1]. LVNC is
thought to be caused by an arrest in the normal process of myocardial
compaction. Normal compaction of the embryonic myocardium pro-
ceeds from the epicardium to the endocardium and from the base to
the apex [1,2]. An insufﬁcient compaction of themyocardiumwill result
in multiple prominent ventricular trabeculations and inter trabecular
recesses and will predominantly include the ventricular endocardium
and the apex of the LV [1]. Both sporadic and familial forms of LVNC
have beendescribed [1]. In familial disease, LVNC is a genetically hetero-
geneous disorder and shares genetic mutations with hypertrophic
cardiomyopathy (HCM), including mutations in genes encoding forgy, Oslo University Hospital,
ay.
Haugaa).
reland Ltd. This is an open access artisarcomere proteins [1]. The prevalence of LVNC is reported between
0.014 and 1.3% [1]. LVNC is diagnosed with increasing frequency
which may be due to higher awareness and more sensitive diagnostic
tools. The use of modern ultrasound technology and cardiac magnetic
resonance (CMR) has increased the detection of morphological features
of LVNC. Furthermore, there is a possibility of over-diagnosing LVNCdue
to the lack of a true gold standard which may challenge the differentia-
tion of LVNC from other cardiomyopathies. Further characterizations of
morphological features in LVNC are therefore needed.
LVNC shares morphologic features with HCMwhich can mimic LVNC
by presence of trabeculation and myocardial crypts [3,4]. Also, LVNC can
present with increased wall thickness, resembling HCM, a phenotype as-
sociated with poor prognosis [5,6]. A true overlap may exist, as reported
in genotyped families expressing both with HCM and LVNC phenotypes,
and both diseases can occur in the same patient [7]. However, treatment
strategies and risk of ventricular arrhythmias differ between LVNC and
HCM and there are limited comparative studies on LVNC versus HCM.
Strain echocardiography can assess regional LV function, and be help-
ful in differentiating between cardiomyopathies [8,9] and reveal changes
in myocardial function, also when ejection fraction (EF) is relativelycle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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graphic parameters in LVNC andHCMpatients and to investigate regional
cardiac function.Wehypothesized that apical function is reduced in LVNC
due to the embryonic uncompleted process of compaction.
2. Methods
2.1. Study population
In this cross sectional study, LVNC and HCM patients were consecutively included
from our outpatient clinic. Data were analyzed retrospectively. Inclusion criteria were a
deﬁnite diagnosis of LVNC or HCM, according to deﬁnitions [4,11,12] conﬁrmed by two in-
dependent investigators. Exclusion criteria were coronary artery disease and myocardial
hypertrophy of obvious non-sarcomeric origin [12]. All participants underwent clinical ex-
amination including New York Heart Association (NYHA) functional classiﬁcation.
Healthy individuals were recruited from hospital staff, medical school and research
laboratories and underwent clinical examination and echocardiographic examination.
All participants gavewritten informed consent. The study compliedwith theDeclaration
of Helsinki and was approved by the Regional Committees for Medical Research Ethics.
2.2. Deﬁnition of LVNC and HCM
Diagnosis of LVNC was deﬁned by echocardiography, according to the criteria of
Jenni et al. (Fig. 1) [4,13]. CMR criteria were used if diagnosis was not fulﬁlled by
echocardiography and was deﬁned as end-diastolic ratio between the non-compacted
and compacted layer N2.3 [14]. The diagnosis of HCM was fulﬁlled by an otherwise
unexplained hypertrophied LV with a maximal ventricular wall thickness (MWT) of
≥15 mm [12].
2.3. Cardiac imaging and clinical data
Echocardiography was performed at inclusion (Vivid 7 or Vivid E9 GE Healthcare,
Horten, Norway) with off-line data analyses (EchoPac® GE Healthcare). The interventric-
ular septum diameter, LV posterior wall diameter, LV end-diastolic diameter and LV end-
systolic diameterwere determined byM-mode or 2-D imaging.MWTwasmeasured fromFig. 1.Echocardiographic images fromapatient fulﬁlling the left ventricular non-compaction (LV
panel). Upper panel A. Image from parasternal short-axis showing thickenedmyocardium consi
(C) endocardial layer. NC/C layer N2 at end-systole. Upper panel B. Trabecular recesses ﬁlle
predominant location of trabeculation in the LV lateral free wall segments. Lower panel A:
fulﬁlling LVNC criteria. Lower panel B: Trabeculations in the inferior wall visible in two-chamball LV segments from the base to the apex of the LV in parasternal short-axis view [12]. EF
was calculated by modiﬁed Simpson's biplane method. Diastolic function was evaluated
by transmitral pulsed Doppler and average e′ from septal and lateral tissue Doppler sam-
plings [15]. Atrial areawasmeasured by using the average of apical four-chamber and api-
cal two-chamber views at ventricular end-systole [16]. Myocardial trabeculations were
deﬁned as localized protrusions of the endocardial surface ≥3mm in diameter, associated
with intra trabecular recesses on 2-D echocardiography [17]. We manually counted all
trabeculations visible in apical 4-chamber, 2-chamber and long-axis view. More than 3
trabeculations apically from the insertion of the papillary muscles were deﬁned as in-
creased LV trabeculation [5,18]. Myocardial longitudinal strain was obtained by speckle
tracking technique from the 3 apical views at frame rate N50/s. The region of interest
was traced in the compact part of the myocardium [19]. LV global longitudinal strain
was averaged from peak longitudinal strains in a 16 segments LV model [20]. LV longitu-
dinal basal strain (6 segments) and longitudinal apical strain (4 segments) were averaged
and analyzed separately. The apical-basal gradient (average of apical strains minus aver-
age basal strains)was calculated. CMRwas performed in a subset of patients on clinical in-
dications as previously described [21].
24 hour Holtermonitoring was performed in all participants. Ventricular arrhythmias
were deﬁned as aborted cardiac arrests, documented ventricular tachycardia and non-
sustained ventricular tachycardia (≥3 consecutive ventricular beats with cycles length
N100 beats/min, lasting b30 s) [22]. All patients underwent progressive maximal cardio-
pulmonary bicycle exercise test with a ramp protocol until exhaustion. Heart rate, blood
pressure and maximum achieved Watt were recorded and metabolic equivalents were
calculated as (12 × (Watt) + 300) × (weight × 3.5)−1 [23].
Genetic testingwas performed as part of thediagnosticwork up in patientswith LVNC
and HCM. We performed DNA sequencing of the genes encoding the sarcomere proteins
MYH7 (NM_000257.2), MYBPC3 (NM_000256.3), TNNI3 (NM_000363.4), TNNT2
(NM_001001430.1), MYL2 (NM_000432.3) and MYL3 (NM_000258.2) as previously de-
scribed [24]. Patients with variants of unknown signiﬁcance were deﬁned as genotype
negative.
2.4. Statistical analyses
Parametric data were presented as mean± standard deviation and compared by un-
paired Student's t-test with Bonferroni post-hoc correction formultiple comparisons, Chi-
square or Fischer's exact test as appropriate. Number of trabeculations was not normallyNC) criteria (upper panel) and a patientwith hypertrophic cardiomyopathy (HCM) (lower
sting of two layers: a thin compacted epicardial layer (C) and a thicker non (N)-compacted
d with blood from the left ventricular cavity. Panel C. Apical four-chamber view with
Posterior wall trabeculations in parasternal short-axis view in a patient with HCM not
er view.
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(SPSS 21.0). The incremental value of EF, number of trabeculations and MWT over diag-
nostic criteria, to assess the diagnosis of LVNCwas studied by calculating the improvement
in global chi-square. Values of p were two-sided and considered signiﬁcant if b0.05.
3. Results
We included 25 patients with LVNC, 50 patients with HCM and 50
healthy individuals (Table 1). The LVNC diagnosis was established by
echocardiography in 21 (84%) of the LVNC cases. Cardiac magnetic
resonance imaging was performed in 9 (36%) LVNC patients and deter-
mined the ﬁnal LVNCdiagnosis in 4 (16%). A family history of cardiomy-
opathy was present in 14 (56%) of LVNC and 39 (78%) of HCM patients
(p=0.06). HCMassociated sarcomeremutationswere found in 9 (36%)
LVNC patients and in 33 (66%) HCM (p b 0.01). Physical capacity was
similar in LVNC and HCM patients by NYHA classiﬁcation (p = 0.59)
and by exercise capacity testing based on metabolic equivalents (p =
0.82) (Table 1). Cardiac arrests occurred more frequently in LVNC com-
pared to HCMpatients (6 (24%) vs. 1 (2.0%), p=0.05) and ventricular ar-
rhythmias were more frequent in LVNC patients (14 (56%) vs. 10 (20%),
p b 0.01). More LVNC patients received an implantable cardioverter deﬁ-
brillator (13 (52%) vs. 12 (24%), p = 0.02).
3.1. LV morphology and function
MWTwas thicker in HCM compared with LVNC (p b 0.001) (Table 2).
All LVNC patients had increased trabeculations (N3) compared to healthy
(10 [5–14] vs. 0 [0–3], p b 0.001) and thesewere most frequently locat-
ed in the apex. Apical trabeculations were present in all (n= 25) LVNC
patients (Fig. 3). In addition, 23 (92%) had lateral and 12 (48%) had in-
ferior trabeculations and 6 (24%) had trabeculations in the apical part of
the septum (Fig. 2). Also HCM patients had increased number of
trabeculations compared to the healthy individuals (2 [0–10] vs. 0 [0–
3], p b 0.001). All LVNC patients (25 (100%)) and 20 (40%) HCMpatients
had N3 trabeculations (p b 0.001). In the 20 HCM patients with N3 LV
trabeculations, regional distribution of trabeculations was similar to
LVNC patients, except for more prevalent lateral trabeculations in
LVNC (p = 0.002) (Fig. 2).
LV global systolic functions by EF and by LV global longitudinal strain
were reduced in LVNC and HCM compared to healthy individuals (all
p b 0.001) (Table 2) and EF was reduced in LVNC compared to HCMTable 1
Clinical characteristics in 50 healthy individuals, in 50 patients with hypertrophic cardiomyopa
Healthy
n = 50
Age (years) 49 ± 19
Women n (%) 15 (60%)
Heart rate (bpm) 62 ± 10
Systolic blood pressure (mm Hg)
Diastolic blood pressure (mm Hg)
NYHA class
NYHA class I (n)
NYHA class II (n)
NYHA class III (n)
NYHA class IV (n)
Metabolic equivalents (3.5 ml/kg/min)
Angiotensin converting enzyme-inhibitor (n)
Angiotensin II-receptor-antagonist (n)
Beta blocker (n)
Acetylsalicylic acid (n)
Warfarin (n)
Diuretics (n)
Ventricular arrhythmia (n)
Cardiac arrest (n)
Implantable cardioverter deﬁbrillator (n)
Mean ± SD, right column shows p-values for ANOVA and Chi square tests. HCM: hypertrophic
sociation functional classiﬁcation.
† p b 0.05 compared to HCM.patients (Table 2). Systolic function by LV global longitudinal strain
and diastolic parameters did not differ between LVNC andHCMpatients
(Table 2). For correct diagnosis, the predictive power of differentiation
between LVNC and HCM increased at each step by adding EF, number
of trabeculations and MWT, respectively, to clinical evaluation (Fig. 3).
3.2. Regional differences
Apical function was worse in LVNC compared to HCM (p = 0.01),
while basal function did not differ (p = 0.82) (Table 2). In LVNC, LV
functionwas homogenously reducedwith no difference between apical
and basal function (−15.7 ± 7.2% vs.−14.7 ± 6.4%, p = 0.35) (Fig. 4).
In contrast, HCMpatients had better apical than basal longitudinal func-
tion (−19.5 ± 4.7% vs.−14.9 ± 4.3%, p b 0.001). The apical-basal gra-
dient was therefore more pronounced in HCM than in LVNC patients
(−4.5±5.1% vs.−1.1± 4.6%, p b 0.01). Also in healthy, apical function
was better than basal (−21.8 ± 2.9% vs.−20.0 ± 1.9%, p b 0.001), but
the apical-basal gradient was less pronounced compared to HCM pa-
tients (−1.7 ± 2.9% vs.−4.5 ± 5.1%, p b 0.01) (Fig. 3).
Therewas nodifference in apical strain in the subset of HCMpatients
with apical hypertrophy compared to theHCMwithout apical hypertro-
phy (−19.5 ± 4.7% vs.−19.5 ± 6.0%, p = 0.99).
4. Discussion
The LVNC phenotype was characterized by more severely and ho-
mogeneously reduced myocardial function and the apical function
was relatively most reduced in LVNC compared to HCM and healthy.
In contrast, HCM patients had preserved EF, but reduced LV global lon-
gitudinal strain with more reduced function in basal segments, while
apical function was relatively preserved. As expected, trabeculations
were most frequent in LVNC. These ﬁndings may help to characterize
patients with LVNC and HCM in families with overlapping phenotypes.
The correct differentiation between LVNC and HCM is important,
given the higher incidence of ventricular arrhythmias in LVNC, as also
shown in this study.
Evolving imaging techniques have increased the diagnosis of LVNC
and patients with a previous HCM diagnosis are occasionally re-
diagnosed with LVNC. Whether this reﬂects a previously overseen LVNC
diagnosis or an over-diagnosis of LVNC is unclear. Furthermore, the genet-
ic etiology in the two conditions is overlapping by the presence of boththy and in 25 patients with left ventricular non-compaction cardiomyopathy.
HCM
n = 50
LVNC
n = 25
p-Value
47 ± 14 47 ± 14 0.67
15 (30%) 19 (38%)† 0.04
63 ± 12 66 ± 18 0.48
134 ± 22 121 ± 21 0.02
79 ± 13 74 ± 15 0.13
1.7 ± 0.8 1.8 ± 0.6 0.59
25 (50%) 9 (36%) 0.18
19 (38%) 13 (52%) 0.18
4 (8%) 3 (12%) 0.42
2 (4%) 0 0.55
7.9 ± 2.6 7.8 ± 2.8 0.82
5 (10%) 10 (40%) b0.01
4 (8%) 4 (16%) 0.42
43 (86%) 23 (92%) 0.71
6 (12%) 6 (24%) 0.19
6 (12%) 8 (32%) 0.05
2 (4%) 8 (32%) b0.01
10 (20%) 14 (56%) b0.01
1 (2%) 6 (24%) b0.01
12 (24%) 13 (52%) 0.02
cardiomyopathy. LVNC: left ventricular non-compaction NYHA class: New York Heart As-
Table 2
Echocardiographic ﬁndings in 50 healthy individuals, in 50 patients with hypertrophic cardiomyopathy and in 25 patients with left ventricular non-compaction cardiomyopathy.
Healthy
n = 50
HCM
n = 50
LVNC
n = 25
p-Value
LV end-diastolic diameter (mm) 52 ± 5.2 48 ± 5.7⁎ 60 ± 9.0⁎† b0.001
LV end-systolic diameter (mm) 33 ± 5.2 32 ± 6.4 47 ± 11.9⁎† b0.001
Interventricular septum diameter (mm) 7.8 ± 1.6 16.2 ± 4.8⁎ 8.7 ± 2.5† b0.001
LV posterior wall diameter (mm) 7.5 ± 1.5 9.2 ± 2.4⁎ 8.0 ± 1.7† b0.001
Maximal wall thickness (mm) 8.5 ± 1.2 18 ± 3.7⁎ 10 ± 2.2† b0.001
Ejection fraction (%) 61 ± 5 57 ± 7⁎ 40 ± 14⁎† b0.001
LV global longitudinal strain (%) −21.1 ± 1.9 −16.8 ± 3.6⁎ −15.2 ± 6.1⁎ b0.001
Basal strain (%) −20.0 ± 1.9 −14.9 ± 4.3⁎ −14.6 ± 6.4⁎ b0.001
Apical strain (%) −21.8 ± 2.9 −19.5 ± 4.7 −15.7 ± 7.2⁎† b0.001
Apical-basal gradient (%) −1.7 ± 2.9 −4.5 ± 5.1⁎ −1.1 ± 4.6† b0.01
Deceleration time (ms) 190 ± 53 191 ± 54 180 ± 69 0.56
E/A 1.4 ± 0.6 1.6 ± 0.9 1.7 ± 1.1 0.31
E (m/s) 0.7 ± 0.2 0.7 ± 0.2 0.7 ± 0.2 0.76
E/e′ 7.1 ± 2.1 11.8 ± 6.1⁎ 11.5 ± 8.9⁎ b0.01
Atrial area (cm2) 17.3 ± 2.9 22.7 ± 6.5⁎ 22.2 ± 5.4⁎ b0.001
Trabeculations (n) 0 (0–3) 2 (0–10)⁎ 10 (5–14)⁎† b0.001
Mean ± SD, right column shows p-values for ANOVA test or Mann-Whitney U test. A: atrial transmitral ﬁlling velocity. E: early transmitral ﬂow velocity. e′: early diastolic myocardial
velocity.GLS: global longitudinal strain. HCM: hypertrophic cardiomyopathy. LV: left ventricle. LVNC: left ventricular non-compaction.
⁎ p b 0.05 compared to healthy individuals.
† p b 0.05 compared to HCM.
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tions. However, the arrhythmic risk seems to be higher in patients
with LVNC compared to HCM, making correct diagnosis important.
MWT was thicker in HCM compared to LVNC, as expected. Further-
more, numbers of trabeculations were most frequent in LVNC.
Trabeculations are common in LVNC, but importantly, not speciﬁc
for LVNC (Fig. 1). Prominent trabeculations may be present also inFig. 2.Distribution of trabeculations among the left ventricular segments in patientswith left
ventricular non-compaction (LVNC) and in patients with hypertrophic cardiomyopathy
(HCM). All patients with left ventricular non-compaction had trabeculations in apical
segments. The distribution was not signiﬁcantly different between the two groups, except
in the lateral segments, where trabeculations were more prevalent those with LVNC
*(p b 0.01). LVNC= left ventricular non-compaction, HCM=hypertrophic cardiomyopathy.patients with dilated cardiomyopathy, hypertensive heart disease and
may increase during pregnancy [4,19,25,26]. Prominent trabeculations
are included in the diagnostic criteria for LVNC by Jenni [4], and by
Stöllberger, including N3 trabeculations visible in a single image plane
[5]. We counted trabeculations from all 3 apical echocardiographic
views. Our ﬁndings support that trabeculations are frequent in LVNC, al-
though N3 trabeculations were also found in 40% of HCM patients. EF
was relatively preserved in HCM as previously reported [27]. However,
a depressed global longitudinal LV function was found in both diseases
as supported by previous reports [28,29]. A reduced LV global longitudi-
nal strain could therefore not be used to separate between the two
diagnoses.
Compaction of the embryonic myocardium proceeds from the epi-
cardium to the endocardium and from the base to the apex [1,2]. An ar-
rest in compaction will therefore predominantly include the ventricular
endocardium and the apex of the LV [1]. From this, the apical segments
should be most frequently involved in the non-compaction pathology.
We found a homogeneously reduced function in basal and apical seg-
ments in LVNC patients. In healthy individuals, we observed amild gra-
dient with better apical than basal function, also described by others
[30]. No such gradient was observed in LVNC. Therefore, apical function
was relatively more reduced than basal function in LVNC compared to
healthy individuals. Our ﬁndings are in line with previous observationsFig. 3. Incremental value of EF, number of trabeculation and MWT over conventional
diagnostic parameters. Addition of EF, number of trabeculation and MWT to
conventional diagnostic criteria in a Likelihood ratios test resulted in a signiﬁcant
improvement in predictive value of differentiation between left ventricular non-
compaction and hypertrophic cardiomyopathy. EF = ejection fraction, MWT =
maximal wall thickness.
Fig. 4. Diagram of left ventricular basal and apical longitudinal strain in patients with
hypertrophic cardiomyopathy (red), in patients with left ventricular non-compaction
cardiomyopathy (blue) and in healthy individuals (green). Patients with hypertrophic
cardiomyopathy had better strain in apical segments compared to basal segments, while
there was no difference in basal and apical function in patients with left ventricular non-
compaction. Furthermore, apical function was signiﬁcantly better in patients with
hypertrophic cardiomyopathy compared to left ventricular non-compaction (p = 0.01).
*p ≤ 0.01, **p b 0.001. Basal = average of peak longitudinal strain from 6 basal
segments, Apical = average of peak longitudinal strain from 4 apical segments. LVNC =
left ventricular non-compaction, HCM = hypertrophic cardiomyopathy. (For
interpretation of the references to color in this ﬁgure legend, the reader is referred to
the web version of this article.)
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pared to base by tissue Doppler imaging in LVNC patients. We suggest
that reduced apical function may be a speciﬁc ﬁnding in LVNC and
may originate from the speciﬁc embryonic mechanism of progressing
myocardial compaction from base to apex. HCM patients had a signiﬁ-
cant apical to basal functional gradient with preserved apical function
compared to a greater loss of basal function. This gradient was more
pronounced in HCM compared to the mild apical-basal gradient ob-
served in our healthy individuals. The pronounced functional gradient
in HCM patients may be explained by themore frequent location of hy-
pertrophy in the basal and septal segments, however apical strain did
not differ between HCM patients with septal versus apical hypertrophy,
supporting our hypothesis that reduced apical function is speciﬁc for
LVNC.4.1. Limitations
An important limitation of this study was that no gold standard ex-
ists in the deﬁnition of LVNC. We deﬁned our LVNC patients according
to the Jenni criteria with thickened myocardium and the two-layer
structure of non-compacted/compacted ratio N2. Other deﬁnitions in-
clude hypertrabeculation deﬁned as N3 trabeculations protruding
from the left ventricle [1,5]. Strain analyses are challenging in both
LVNC and in HCM due to the varying intra individual wall thickness
which may inﬂuence strain measurements. We carefully placed the
measurements in the compacted area in LVNC and in themidventricular
wall in HCM patients to obtain reproducibility.5. Conclusion
We found homogeneously reduced LV function in LVNC, as opposed
to preserved apical and more reduced basal function in HCM, which
may represent speciﬁc differences in embryogenesis and pathogenesis
in the two cardiomyopathies. LVNC patients had increased number of
trabeculations, thinner MWT, and lower EF compared to HCM patients
and assessment of these parameters may help to characterize LVNC in
patients with overlapping phenotypes.Disclosures
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